Page-2 of Remdesivir

Remdesivir Shortage in India

April 13, 2021

Remdesivir is an injectable anti-virus. It is injected to prevent replication of the virus. The Remdesivir was created in 2014. It was manufactured in large scale to treat Ebola. Later it was used to treat SARS and MERS. Recently, after ..

Month: 

What is Emergency Use Authorization?

December 3, 2020

Recently, several drug makers are seeking Emergency Use Authorisation (EUA) for the COVID-19 vaccine. Pfizer had applied for the EUA in UK and has been approved by the Medicines and Healthcare Products Regulatory Agency of the country. Also, the Serum ..

Month: 

India contributes 3,000 vials of Remdesivir to Myanmar

October 5, 2020

On October 5, 2020, the Government of India contributed 3,000 vials to Myanmar under the framework of India-Myanmar Foreign Office Consultation. Highlights The 3,000 vials of Remdesivir drug was provided by Army Chief Naravane to the Myanmar State counsellor Aung ..

Month: 

Zydus Cadila launched the cheapest generic version of Remdesivir in India

August 13, 2020

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug Remdesivir in India to treat the deadly COVID 19 pandemic. The version has been launched after reports of a shortage of the drugs in the hospitals of the ..

Month: 

“Dexamethasone” added to COVID-19 treatment protocol

June 29, 2020

The Union Ministry of Health and Family Welfare recently included the use of steroid Dexamethasone in COVID-19 treatment. The ministry has also recommended the use of Remdesivir on patients that are moderately ill. Hydroxychloroquine is to be used during early ..

Month: 

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

June 22, 2020

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals ..

Month: